The problem: lot genealogy pieced together by hand
When a lot fails release, teams need to know what went into it and what else used the same inputs. Reconstructing that across systems takes days.
A drug product lot fails release. The team needs its exact recipe lots, the results of the drug substance lot it used, and every other lot that used the same input. Across separate systems, that can take days.
What this demo shows
- Check the lot against its release specification.
- Compare it with the lots that passed.
- Read the exact lots on its recipe and open the drug substance lot results.
- Confirm which lots used that drug substance lot.
Why it matters
In biopharma, the speed of a lot investigation affects supply. Connected records make genealogy a matter of following links.
Finding every lot that used the same drug substance lot shows the full scope of the issue early, before more lots are released.
See it with your own data
This video is part of LIMS for R&D. To see how it would work with your own formulations and records, request a demo. Our team replies within 30 minutes during business hours.
Read the transcript
One clinical lot failed release. Where did the problem start? Its results sit on the lot record in Uncountable, checked against the release specification. Two SEC results are out of limit. Next to the three lots that passed, only this one fails. Same formulation, same process, only the drug substance lot differs. Its recipe names the exact drug substance lot it used.
That drug substance lot was already outside its acceptance limits. Related experiments shows every drug product lot that used it. Only this one did. From a failed lot to its source, Uncountable keeps every lot, recipe, and result in one platform.
